This study aimed to develop a systematic approach to classifying childhood cancer-related admissions in administrative data into categories that reflected clinical practice and predicted resource use.
Substantial health care savings can be achieved by reducing complications from cancer surgery, writes Marah Short, associate director of the Health Policy Forum.
Marijuana decriminalization and legalization have gone past being a trend and are settling in as federal policy, writes nonresident fellow Gary Hale, a 31-year veteran of the Drug Enforcement Administration. This policy brief includes recommendations for how the DEA can adjust its policies to adopt a new paradigm on marijuana policy.
Neal Lane, senior fellow in science and technology policy, testified before the Senate Committee on Commerce, Science and Transportation on July 17, 2014. Lane is co-chair of the American Academy of Arts and Science's project on New Models for U.S. Science and Technology Policy, and his testimony addressed the project's objective of sustaining a long-term, nonpartisan, national focus on science and technology policy issues of vital importance to the country.
It is inconceivable to imagine our nation today without the gains of the Civil Rights Act. It is impossible to understand why the issue was so divisive then, since it is such an obvious right and moral proposition. Similarly, let us hope we will look back at the Affordable Care Act 20 years from now and wonder why it was such a contentious topic in 2014.
Biotechnology scientists must be aware of the broad patent landscape and push for new patent and licensing guidelines, according to a new paper from the Baker Institute.
Cancer drug shortages are almost uniquely associated with generic drugs (small profit margins) and rarely with patented drugs (large profit margins). They are common in the U.S., but uncommon in Europe and elsewhere, where generic drug prices are on average higher than in the U.S. This suggests the main cause of drug shortages is economic.
Baker Institute health policy experts Hagop M. Kantarjian and Vivian Ho explain why Texas, which holds the notorious record of the highest rate of uninsured citizens in the U.S., should follow many Republican-led states that are now reconsidering the Medicaid expansion program under Obamacare.
